NCT04753567

nCap Pain Relief Patch vs. Placebo

nCap Medical Nano-Capacitive Pain Relief Patch vs Placebo, a Prospective Randomized Controlled Trial

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 70 (estimated)
• Sponsor: nCap Medical · Industry
• Sex: All
• Age: 40 Years – 79 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to determine whether use of the nCap Medical Nano-Capacitive pain relief patch reduces subject pain as measured by subject pain scores, WOMAC scores (pain, stiffness and physical function), global assessment scores, and pain medication change as compared to participants randomly assigned to the sham patch group.

Conditions

• Osteoarthritis, Knee

Interventions

Type	Name	Description
DEVICE	nCap pain relief patch	Each participant will be randomly assigned to sham or actual patch. Patches will be worn for 3 weeks. Pain and quality of life will be assessed and compared between groups
DEVICE	Sham Patch	Sham patch will be worn for 3 weeks exactly like actual pain patch

Timeline

• Start date: 2021-04-16
• Primary completion: 2022-04-01
• Completion: 2022-04-01
• First posted: 2021-02-15
• Last updated: 2021-04-20

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study